The role of GLP-1 receptor agonists in CVD prevention

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Newest ESC guidelines on diabetes and CVD
Newest ESC guidelines on diabetes and CVD
Reducing cardiovascular risk in diabetes: The next preventive challenge
Newest ESC guidelines on diabetes and CVD
- Prof. Francesco Cosentino
The role for primary care in reducing CV risk in diabetes
The role for primary care in reducing CV risk in diabetes
Reducing cardiovascular risk in diabetes: The next preventive challenge
The role for primary care in reducing CV risk in diabetes
- Prof. Richard Hobbs, MD